483 Albany Molecular Research May 2006

483 Albany Molecular Research May 2006

Brenda King FDA, Philip Mclaughlin FDA, Anthony Warchut FDA, Amber Wardwell FDA$119.00 - Available Now

FDA investigators audited the Albany Molecular Research - Burlington, MA, United States facility and issued inspectional observations (via FDA 483) on 24 May 2006.

Product details

  • Category: Medical Devices & Rad Health / Human Drugs
  • Inspection end: 24 May 2006
  • Location: Burlington, United States
  • FEI: 3002951540
Add To Cart